194 related articles for article (PubMed ID: 21385167)
1. Inference for the effect of treatment on survival probability in randomized trials with noncompliance and administrative censoring.
Nie H; Cheng J; Small DS
Biometrics; 2011 Dec; 67(4):1397-405. PubMed ID: 21385167
[TBL] [Abstract][Full Text] [Related]
2. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
Odondi L; McNamee R
Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
[TBL] [Abstract][Full Text] [Related]
3. Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.
Chiba Y
Contemp Clin Trials; 2010 Jan; 31(1):12-7. PubMed ID: 19879376
[TBL] [Abstract][Full Text] [Related]
4. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
Wang Y; Berlin JA; Pinheiro J; Wilcox MA
Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
[TBL] [Abstract][Full Text] [Related]
5. Making sense of clinical trial data: is inverse probability of censoring weighted analysis the answer to crossover bias?
Rimawi M; Hilsenbeck SG
J Clin Oncol; 2012 Feb; 30(4):453-8. PubMed ID: 22215751
[TBL] [Abstract][Full Text] [Related]
6. Impact of censoring on learning Bayesian networks in survival modelling.
Stajduhar I; Dalbelo-Basić B; Bogunović N
Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
[TBL] [Abstract][Full Text] [Related]
7. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
Chan KC
Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
[TBL] [Abstract][Full Text] [Related]
8. Administrative and artificial censoring in censored regression models.
Joffe MM
Stat Med; 2001 Aug; 20(15):2287-304. PubMed ID: 11468764
[TBL] [Abstract][Full Text] [Related]
9. Nonparametric inference on median residual life function.
Jeong JH; Jung SH; Costantino JP
Biometrics; 2008 Mar; 64(1):157-63. PubMed ID: 17501936
[TBL] [Abstract][Full Text] [Related]
10. Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
Julian-Reynier C; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; Maraninchi D;
J Clin Oncol; 2007 Jul; 25(21):3038-44. PubMed ID: 17536083
[TBL] [Abstract][Full Text] [Related]
11. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
Lui KJ
J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
[TBL] [Abstract][Full Text] [Related]
12. Principal stratification with predictors of compliance for randomized trials with 2 active treatments.
Roy J; Hogan JW; Marcus BH
Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993
[TBL] [Abstract][Full Text] [Related]
13. Sequential monitoring of randomization tests: stratified randomization.
Zhang Y; Rosenberger WF; Smythe RT
Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
[TBL] [Abstract][Full Text] [Related]
14. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
Taylor L; Zhou XH
Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
[TBL] [Abstract][Full Text] [Related]
15. A method for sequential analysis of survival data with nonproportional hazards.
Sooriyarachchi MR; Whitehead J
Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
Levin BJ; Thompson G; Mitsumoto LH; Kaufmann P
Neurology; 2006 Jun; 66(11):1786-7; author reply 1786-7. PubMed ID: 16769973
[No Abstract] [Full Text] [Related]
17. Analyses of cumulative incidence functions via non-parametric multiple imputation.
Ruan PK; Gray RJ
Stat Med; 2008 Nov; 27(27):5709-24. PubMed ID: 18712779
[TBL] [Abstract][Full Text] [Related]
18. Discussions.
Have TT
Biometrics; 2007 Sep; 63(3):654-5. PubMed ID: 17824997
[No Abstract] [Full Text] [Related]
19. Noncompliance in cancer screening trials.
Gareen IF
Clin Trials; 2007; 4(4):341-9. PubMed ID: 17848495
[TBL] [Abstract][Full Text] [Related]
20. An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.
Hadley J; Polsky D; Mandelblatt JS; Mitchell JM; Weeks JC; Wang Q; Hwang YT;
Health Econ; 2003 Mar; 12(3):171-86. PubMed ID: 12605463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
